Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02337179 · ClinicalTrials.gov registry record · NA

Male Circumcision Services for HIV Prevention in the Dominican Republic

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
539
Enrollment target

NCT02337179: Completed NA study, sponsored by University of Illinois at Chicago.

NCT02337179 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 539 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02337179, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
539 participants
Enrollment target

Study Summary

The purpose of this study is to determine the feasibility of introducing voluntary medical male circumcision as a form of HIV prevention in high HIV prevalence areas in the Dominican Republic.

Interventions

  • PROCEDURE Voluntary medical male circumcision

Trial Details

FieldValue
Enrollment Target 539 participants
Start Date 2011-02
Est. Completion 2017-04-01
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT02337179 record still lists

NCT02337179 is an interventional study that assigns participants to a tested intervention. The registered 539 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 1 intervention - of which Voluntary medical male circumcision is the first listed.

NCT02337179 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02337179 about?

NCT02337179 is a clinical study titled "Male Circumcision Services for HIV Prevention in the Dominican Republic". The purpose of this study is to determine the feasibility of introducing voluntary medical male circumcision as a form of HIV prevention in high HIV prevalence areas in the Dominican Republic.

What is the current status of trial NCT02337179?

This trial is currently completed. It is a NA study. The enrollment target is 539 participants. The study started on 2011-02. Estimated completion is 2017-04-01.

What interventions are being tested in trial NCT02337179?

The interventions under investigation include: Voluntary medical male circumcision (PROCEDURE).

Who is sponsoring clinical trial NCT02337179?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02337179's enrollment target sits among peer trials

539 188th of 2000 higher than 1,813 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04557462 · 540 participants · Phase 3

    A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  • NCT04956640 · 540 participants · Phase 1

    Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

  • NCT05429892 · 540 participants · NA

    FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

  • NCT05549297 · 540 participants · Phase 3

    Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02337179, the US trial registry maintained by the National Library of Medicine. NCT02337179 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.